Changes in the Myocardial Interstitium and Contribution to the Progression of Heart Failure

被引：42
作者：
Eckhouse, Shaina R. [3 ]
Spinale, Francis G. [1 ,2 ]
机构：
[1] Univ S Carolina, Sch Med, CVCTRC, Dept Cell Biol & Anat, Columbia, SC 29208 USA
[2] Med Univ S Carolina, Dept Surg, Charleston, SC 29425 USA
[3] Med Univ S Carolina, Div Cardiothorac Surg, Dept Surg, Charleston, SC 29425 USA
来源：
HEART FAILURE CLINICS | 2012年 / 8卷 / 01期
关键词：
Interstitium; Extracellular matrix; Heart failure; Pressure overload hypertrophy; Dilated cardiomyopathy; Myocardial infarction; GROWTH-FACTOR-BETA; LEFT-VENTRICULAR HYPERTROPHY; ASSIST DEVICE SUPPORT; AORTIC-VALVE DISEASE; IDIOPATHIC DILATED CARDIOMYOPATHY; COLLAGEN CROSS-LINKING; FAILING HUMAN HEART; MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX; TISSUE INHIBITOR;
D O I：
10.1016/j.hfc.2011.08.012
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The myocardial interstitium is highly organized and orchestrated, whereby small disruptions in composition, spatial relationships, or content lead to altered myocardial systolic and/or diastolic performance. These changes in extracellular matrix structure and function are important in the progression to heart failure in pressure overload hypertrophy, dilated cardiomyopathy, and ischemic heart disease. The myocardial interstitium is not a passive entity, but rather a complex and dynamic microenvironment that represents an important structural and signaling system within the myocardium.
引用
收藏
页码：7 / +
页数：15
相关论文
共 109 条
[1]   Matrix metalloproteinases/tissue inhibitors of metalloproteinases - Relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease [J].
Ahmed, SH ;
Clark, LL ;
Pennington, WR ;
Webb, CS ;
Bonnema, DD ;
Leonardi, AH ;
McClure, CD ;
Spinale, FG ;
Zile, MR .
CIRCULATION, 2006, 113 (17) :2089-2096
[2]   An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness [J].
Asif, M ;
Egan, J ;
Vasan, S ;
Jyothirmayi, GN ;
Masurekar, MR ;
Lopez, S ;
Williams, C ;
Torres, RL ;
Wagle, D ;
Ulrich, P ;
Cerami, A ;
Brines, M ;
Regan, TJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) :2809-2813
[3]   Changes in extracellular collagen matrix alter myocardial systolic performance [J].
Baicu, CF ;
Stroud, JD ;
Livesay, VA ;
Hapke, E ;
Holder, J ;
Spinale, FG ;
Zile, MR .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 284 (01) :H122-H132
[4]   Increased expression of extracellular matrix regulators TIMP1 and MMP1 in deteriorating heart failure [J].
Barton, PJR ;
Birks, EJ ;
Felkin, LE ;
Cullen, ME ;
Koban, MU ;
Yacoub, MH .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2003, 22 (07) :738-744
[5]   Decreased Expression of Thrombospondin-1 in Failing Hearts May Favor Ventricular Remodeling [J].
Batlle, M. ;
Perez-Villa, F. ;
Lazaro, A. ;
Garcia-Pras, E. ;
Vallejos, I. ;
Sionis, A. ;
Castel, M. A. ;
Roig, E. .
TRANSPLANTATION PROCEEDINGS, 2009, 41 (06) :2231-2233
[6]   Load-dependent and -independent regulation of proinflammatory cytokine and cytokine receptor gene expression in the adult mammalian heart [J].
Baumgarten, G ;
Knuefermann, P ;
Kalra, D ;
Gao, F ;
Taffet, GE ;
Michael, L ;
Blackshear, PJ ;
Carballo, E ;
Sivasubramanian, N ;
Mann, DL .
CIRCULATION, 2002, 105 (18) :2192-2197
[7]   MOLECULAR SIGNALING MECHANISMS CONTROLLING GROWTH AND FUNCTION OF CARDIAC FIBROBLASTS [J].
BOOZ, GW ;
BAKER, KM .
CARDIOVASCULAR RESEARCH, 1995, 30 (04) :537-543
[8]  
BORDER WA, 1994, NEW ENGL J MED, V331, P1286
[9]   ALTERATION OF THE CONNECTIVE-TISSUE NETWORK OF STRIATED-MUSCLE IN COPPER DEFICIENT RATS [J].
BORG, TK ;
KLEVAY, LM ;
GAY, RE ;
SIEGEL, R ;
BERGIN, ME .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1985, 17 (12) :1173-1183
[10]   Thrombospondins as matricellular modulators of cell function [J].
Bornstein, P .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (08) :929-934
12345678910